CVS Health Corp (NYSE:CVS) Shares Bought by Paragon Capital Management LLC

Paragon Capital Management LLC raised its stake in CVS Health Corp (NYSE:CVS) by 4.5% during the second quarter, HoldingsChannel reports. The institutional investor owned 94,837 shares of the pharmacy operator’s stock after purchasing an additional 4,055 shares during the quarter. CVS Health comprises about 2.3% of Paragon Capital Management LLC’s investment portfolio, making the stock its 18th biggest position. Paragon Capital Management LLC’s holdings in CVS Health were worth $5,168,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Dimensional Fund Advisors LP increased its stake in shares of CVS Health by 28.3% during the 4th quarter. Dimensional Fund Advisors LP now owns 13,790,753 shares of the pharmacy operator’s stock worth $903,574,000 after purchasing an additional 3,041,266 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of CVS Health by 36.2% during the 4th quarter. Geode Capital Management LLC now owns 16,462,292 shares of the pharmacy operator’s stock worth $1,076,697,000 after purchasing an additional 4,376,604 shares during the last quarter. Nordea Investment Management AB increased its stake in shares of CVS Health by 11.7% during the 4th quarter. Nordea Investment Management AB now owns 12,086,430 shares of the pharmacy operator’s stock worth $791,897,000 after purchasing an additional 1,269,136 shares during the last quarter. Surevest Inc. purchased a new stake in shares of CVS Health during the 4th quarter worth approximately $308,000. Finally, HighPoint Advisor Group LLC increased its stake in shares of CVS Health by 4.4% during the 4th quarter. HighPoint Advisor Group LLC now owns 13,457 shares of the pharmacy operator’s stock worth $940,000 after purchasing an additional 570 shares during the last quarter. 75.20% of the stock is currently owned by institutional investors.

NYSE:CVS traded down $1.02 during trading hours on Friday, hitting $61.03. The stock had a trading volume of 2,054,460 shares, compared to its average volume of 9,224,633. The company has a 50 day simple moving average of $57.21 and a two-hundred day simple moving average of $56.35. The company has a debt-to-equity ratio of 1.39, a current ratio of 0.95 and a quick ratio of 0.64. CVS Health Corp has a one year low of $51.72 and a one year high of $82.15. The firm has a market capitalization of $80.06 billion, a price-to-earnings ratio of 8.62, a P/E/G ratio of 1.35 and a beta of 0.90.



CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.89 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.70 by $0.19. CVS Health had a net margin of 1.91% and a return on equity of 16.15%. The firm had revenue of $63.43 billion during the quarter, compared to the consensus estimate of $62.66 billion. During the same period last year, the firm earned $1.69 EPS. The business’s quarterly revenue was up 35.2% compared to the same quarter last year. Equities research analysts anticipate that CVS Health Corp will post 6.96 earnings per share for the current year.

The company also recently declared a quarterly dividend, which was paid on Friday, August 2nd. Shareholders of record on Thursday, July 25th were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 3.28%. The ex-dividend date was Wednesday, July 24th. CVS Health’s payout ratio is 28.25%.

A number of research firms recently weighed in on CVS. Morgan Stanley reiterated a “buy” rating and issued a $74.00 price objective on shares of CVS Health in a research note on Sunday, August 11th. Credit Suisse Group lowered shares of CVS Health from an “outperform” rating to a “neutral” rating and reduced their price objective for the company from $73.00 to $61.00 in a research note on Monday, April 29th. Citigroup lifted their price objective on shares of CVS Health from $68.00 to $72.00 and gave the company a “buy” rating in a research note on Thursday, August 8th. BMO Capital Markets set a $63.00 price objective on shares of CVS Health and gave the company a “hold” rating in a research note on Friday, May 3rd. Finally, Mizuho set a $71.00 price objective on shares of CVS Health and gave the company a “buy” rating in a research note on Wednesday, June 5th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating, sixteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $75.14.

About CVS Health

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

See Also: How does equity income fit into an investing strategy?

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.